Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 3/20 | 0.36 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP3 | P08254 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 3/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3087571 | 1.00 | LAP3 (0.36) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL3098133 | 0.85 | LAP3 (0.38) | LAP3FDPSANPEPERAP1 | |
| SCHEMBL3098142 | 0.85 | LAP3 (0.38) | LAP3FDPSANPEPERAP1 | |
| SCHEMBL2985696 | 0.84 | FDPS (0.36) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL2985694 | 0.84 | FDPS (0.36) | LAP3FDPSMETAP1MMP1MMP2 | |
| SCHEMBL3100608 | 0.81 | FDPS (0.33) | LAP3FDPSANPEPERAP1 | |
| SCHEMBL3100596 | 0.81 | FDPS (0.33) | LAP3FDPSANPEPERAP1 | |
| SCHEMBL8613007 | 0.79 | PGR (0.36) | FDPS | |
| Hydrochloric Acid SCHEMBL8615965 | 0.77 | PGR (0.35) | FDPS | |
| SCHEMBL3109138 | 0.75 | FDPS (0.37) | LAP3FDPSMETAP1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100247463-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2010-09-30 | — | — | US | claimed |